Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Nipocalimab Administered to Adults with Generalized
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Janssen Research & Development, LLC
Start Date
July 19, 2021
End Date
November 10, 2026
Administered By
School of Medicine
Awarded By
Janssen Research & Development, LLC
Start Date
July 19, 2021
End Date
November 10, 2026